Epidemiological, clinical and radiological characteristics of people with neurocysticercosis in Tanzania-A cross-sectional study.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
11
08
2022
accepted:
26
10
2022
entrez:
28
11
2022
pubmed:
29
11
2022
medline:
1
12
2022
Statut:
epublish
Résumé
Neurocysticercosis (NCC) is common among people with epilepsy in low-resource settings. Prevalence of NCC and radiological characteristics of patients with NCC vary considerably even within small areas but differences have been poorly characterized so far. We conducted a cross-sectional study between August 2018 and April 2020 in three district hospitals in southern Tanzania (Ifisi, Tukuyu and Vwawa). Patients with and without epileptic seizures were included in this study. All patients were tested with a novel antibody-detecting point-of-care test for the diagnosis of Taenia solium cysticercosis. All test positives and a subset of test negatives had a further clinical work-up including medical examination and computed tomography of the brain. NCC was defined according to the Del Brutto criteria. We assessed epidemiological, clinical and radiological characteristics of patients with NCC by presence of epileptic seizures and by serology status. In all three district hospitals, more than 30% of all people with epileptic seizures (PWE) had NCC lesions in their brain (38% in Vwawa, 32% in Tukuyu and 31% in Ifisi). Most PWE with NCC had multiple lesions and mostly parenchymal lesions (at least 85%). If patients were serologically positive, they had in the median more lesions than serologically negative patients (15 [interquartile range 8-29] versus 5 [1.8-11]), and only serologically positive patients had active stage lesions. Furthermore, serologically positive PWE had more lesions than serologically positive people without epileptic seizures (10.5 [7-23]), and more often had active lesions. PWE diagnosed with NCC (n = 53) were older, and more commonly had focal onset seizures (68% versus 44%, p = 0.03) and headache episodes (34% versus 14%, p = 0.06), which were also stronger than in PWE without NCC (p = 0.04). NCC is common among PWE. A combination of clinical and serological factors could help to establish an algorithm to identify patients potentially suffering from active NCC, who benefit from further clinical investigation including neuroimaging.
Sections du résumé
BACKGROUND
Neurocysticercosis (NCC) is common among people with epilepsy in low-resource settings. Prevalence of NCC and radiological characteristics of patients with NCC vary considerably even within small areas but differences have been poorly characterized so far.
METHODS
We conducted a cross-sectional study between August 2018 and April 2020 in three district hospitals in southern Tanzania (Ifisi, Tukuyu and Vwawa). Patients with and without epileptic seizures were included in this study. All patients were tested with a novel antibody-detecting point-of-care test for the diagnosis of Taenia solium cysticercosis. All test positives and a subset of test negatives had a further clinical work-up including medical examination and computed tomography of the brain. NCC was defined according to the Del Brutto criteria. We assessed epidemiological, clinical and radiological characteristics of patients with NCC by presence of epileptic seizures and by serology status.
RESULTS
In all three district hospitals, more than 30% of all people with epileptic seizures (PWE) had NCC lesions in their brain (38% in Vwawa, 32% in Tukuyu and 31% in Ifisi). Most PWE with NCC had multiple lesions and mostly parenchymal lesions (at least 85%). If patients were serologically positive, they had in the median more lesions than serologically negative patients (15 [interquartile range 8-29] versus 5 [1.8-11]), and only serologically positive patients had active stage lesions. Furthermore, serologically positive PWE had more lesions than serologically positive people without epileptic seizures (10.5 [7-23]), and more often had active lesions. PWE diagnosed with NCC (n = 53) were older, and more commonly had focal onset seizures (68% versus 44%, p = 0.03) and headache episodes (34% versus 14%, p = 0.06), which were also stronger than in PWE without NCC (p = 0.04).
CONCLUSION
NCC is common among PWE. A combination of clinical and serological factors could help to establish an algorithm to identify patients potentially suffering from active NCC, who benefit from further clinical investigation including neuroimaging.
Identifiants
pubmed: 36441777
doi: 10.1371/journal.pntd.0010911
pii: PNTD-D-22-01035
pmc: PMC9704569
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010911Informations de copyright
Copyright: © 2022 Stelzle et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Epilepsy Res. 2018 Sep;145:145-152
pubmed: 30007239
BMC Vet Res. 2020 Sep 3;16(1):325
pubmed: 32883326
Pathog Glob Health. 2012 Sep;106(5):261-74
pubmed: 23265550
PLoS Negl Trop Dis. 2019 Dec 6;13(12):e0007751
pubmed: 31809501
BMJ Glob Health. 2018 Oct 31;3(5):e000895
pubmed: 30483405
Epilepsia. 2009 May;50(5):987-93
pubmed: 19054402
Lancet Neurol. 2014 Dec;13(12):1202-15
pubmed: 25453460
Am J Trop Med Hyg. 2018 Sep;99(3):729-734
pubmed: 29943721
Clin Infect Dis. 2018 Apr 3;66(8):e49-e75
pubmed: 29481580
Front Neurol. 2018 May 02;9:276
pubmed: 29770117
Trends Parasitol. 2020 Oct;36(10):826-834
pubmed: 32819826
PLoS Negl Trop Dis. 2011 Jun;5(6):e1185
pubmed: 21666796
Afr Health Sci. 2012 Jun;12(2):186-92
pubmed: 23056026
BMC Neurol. 2022 Aug 26;22(1):321
pubmed: 36028820
Epilepsia. 2008 Sep;49(9):1491-503
pubmed: 18557778
PLoS Negl Trop Dis. 2017 Jun 9;11(6):e0005646
pubmed: 28599004
Lancet Neurol. 2019 Apr;18(4):357-375
pubmed: 30773428
PLoS Negl Trop Dis. 2022 Nov 7;16(11):e0010870
pubmed: 36342903
Prog Clin Parasitol. 1994;4:77-116
pubmed: 7948938
Parasit Vectors. 2021 Jan 29;14(1):88
pubmed: 33514421
J Neurol Sci. 2017 Jan 15;372:202-210
pubmed: 28017213
Seizure. 2020 Jan 7;76:1-11
pubmed: 31935478
Parasitol Int. 2006;55 Suppl:S121-6
pubmed: 16352464
PLoS Negl Trop Dis. 2022 Sep 15;16(9):e0010675
pubmed: 36108075
Diagnostics (Basel). 2021 Aug 24;11(9):
pubmed: 34573870
Seizure. 2016 Mar;36:49-56
pubmed: 26938970
J Travel Med. 2022 Oct 12;:
pubmed: 36222148
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Parasitology. 2002 Jun;124(Pt 6):657-62
pubmed: 12118722
Acta Trop. 2003 Jun;87(1):95-101
pubmed: 12781383
Trans R Soc Trop Med Hyg. 2010 Apr;104(4):243-50
pubmed: 20116079